Stocktoria
Bausch Health Companies Inc. BHC
Bausch Health Companies Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.3B | $9.6B | $8.8B | $8.1B | $8.4B | $8.0B | $8.6B | $8.4B | $8.7B | $9.7B |
| SG&A expense | $3.4B | $3.3B | $2.9B | $2.6B | $2.6B | $2.4B | $2.6B | $2.5B | $2.6B | $2.8B |
| Operating income | $1.8B | $1.5B | $963.0M | $454.0M | $450.0M | $676.0M | -$203.0M | -$2.4B | $102.0M | -$566.0M |
| Income tax | $247.0M | $239.0M | $221.0M | $83.0M | -$87.0M | -$375.0M | -$54.0M | -$10.0M | -$4.1B | -$27.0M |
| Net income | $157.0M | -$46.0M | -$592.0M | -$225.0M | -$948.0M | -$560.0M | -$1.8B | — | — | — |
| EPS (diluted) | $0.42 | $-0.13 | $-1.62 | $-0.62 | $-2.64 | $-1.58 | $-5.08 | $-11.81 | $6.83 | $-6.94 |
| Operating cash flow | $1.4B | $1.6B | $1.0B | -$728.0M | $1.4B | $1.1B | $1.5B | $1.5B | $2.3B | $2.1B |
| Free cash flow | $1.0B | $1.3B | $817.0M | -$946.0M | $1.2B | $809.0M | $1.2B | $1.3B | $2.1B | $1.9B |
| Cash & equivalents | $1.3B | $1.2B | $947.0M | $564.0M | $582.0M | $605.0M | $3.2B | $721.0M | $720.0M | $542.0M |
| Inventory | $1.6B | $1.6B | $1.5B | $1.1B | $993.0M | $1.1B | $1.1B | $934.0M | $1.0B | $1.1B |
| Total assets | $26.4B | $26.5B | $27.4B | $25.7B | $29.2B | $31.2B | $33.9B | $32.5B | $37.5B | $43.5B |
| Total liabilities | $26.0B | $26.8B | $27.4B | $25.4B | $29.2B | $30.6B | $32.7B | $29.7B | $31.6B | $40.3B |
| Shareholders' equity | -$554.0M | -$1.3B | -$1.0B | -$692.0M | -$106.0M | $605.0M | $1.1B | $2.8B | $5.9B | $3.3B |
Growth · year-over-year · Revenue CAGR 0.7%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +6.7% | +9.9% | +7.8% | -3.7% | +5.1% | -6.7% | +2.6% | -3.9% | -9.8% | -7.4% |
| EPS growth | — | — | — | — | — | — | — | -272.9% | — | — |
| Free cash flow growth | -20.4% | +54.2% | — | -181.8% | +43.0% | -34.3% | -8.4% | -36.6% | +14.4% | -8.4% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.